Glioblastoma Multiforme Therapeutics Market

Glioblastoma multiforme (GBM) is among the most difficult of tumors to treat, and despite all efforts, median overall survival remains at approximately 12 months. Malignant gliomas are included in the category of rare diseases, and the orphan drug status is granted for the drug candidates in the pipeline.
Glioblastoma Multiforme Therapeutics Market aims to provide a comprehensive presentation of the global market for Glioblastoma Multiforme (GBM) Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glioblastoma Multiforme (GBM) Therapeutics. Glioblastoma Multiforme Therapeutics Market contains market size and forecasts of Glioblastoma Multiforme (GBM) Therapeutics in global, including the following market information:
Global Glioblastoma Multiforme (GBM) Therapeutics Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Glioblastoma Multiforme (GBM) Therapeutics market was valued at US$ 564.1 million in 2022 and is projected to reach US$ 990.5 million by 2029, at a CAGR of 8.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America dominated the global market in 2017, accounting for over 35% share in terms of revenue. Europe was anOthers major market for glioblastoma multiforme (GBM) therapeutics in 2017. Technological advancement is a major driver of the market in North America and Europe.
We surveyed the Glioblastoma Multiforme (GBM) Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glioblastoma Multiforme (GBM) Therapeutics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Glioblastoma Multiforme (GBM) Therapeutics Market Segment Percentages, by Type, 2022 (%)
ChemOthersapy
Targeted Drug Therapy
Radiation Therapy
Global Glioblastoma Multiforme (GBM) Therapeutics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Glioblastoma Multiforme (GBM) Therapeutics Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Glioblastoma Multiforme (GBM) Therapeutics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Glioblastoma Multiforme (GBM) Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glioblastoma Multiforme (GBM) Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Glioblastoma Multiforme (GBM) Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Roche
Arbor Pharmaceuticals
Pfizer
AbbVie
Amgen
Bristol-Myers Squibb
Sun Pharmaceuticals
Teva Pharmaceutical
Emcure Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Glioblastoma Multiforme (GBM) Therapeutics, market overview.
Chapter 2: Global Glioblastoma Multiforme (GBM) Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Glioblastoma Multiforme (GBM) Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Glioblastoma Multiforme (GBM) Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.